3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
186
Carcinoma, Non-Small-Cell Lung
144
Multiple Myeloma
120
Prostatic Neoplasms
118
Leukemia, Myeloid, Acute
77
Neoplasms
75
Colorectal Neoplasms
75
Melanoma
72
Neoplasm Metastasis
66
Lymphoma
66
Squamous Cell Carcinoma of Head and Neck
64
Lung Neoplasms
64
Pancreatic Neoplasms
54
Ovarian Neoplasms
50
Sarcoma
46
Carcinoma, Renal Cell
45
Triple Negative Breast Neoplasms
43
Glioblastoma
42
Urinary Bladder Neoplasms
41
Leukemia, Lymphocytic, Chronic, B-Cell
41
Carcinoma, Hepatocellular
41
Recurrence
40
Head and Neck Neoplasms
38
Hematologic Neoplasms
37
Lymphoma, Large B-Cell, Diffuse
36
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Myelodysplastic Syndromes
35
Lymphoma, Non-Hodgkin
34
Brain Neoplasms
34
Lymphoma, Mantle-Cell
31
Interventions
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Etoposide
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Active not recruiting
×
Retinal Neoplasms
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled